Lymphoma Day of Education 2025 Evaluations
-
From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies
Evaluation for Credit
-
Advancing Pharmacist Expertise in Relapsed/Refractory Follicular Lymphoma: Navigating Novel Therapies and Optimizing Patient Outcomes
Evaluation for Credit
-
Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies in Follicular Lymphoma
Evaluation for Credit
-
Optimizing Patient Outcomes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies
Evaluation for Credit
-
Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma
Evaluation for Credit